These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2188335)
61. Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen. Clemmensen O; Knudsen HE Contact Dermatitis; 1980 Aug; 6(5):305-8. PubMed ID: 7418388 [TBL] [Abstract][Full Text] [Related]
62. Fraction A: a new immunotherapeutic approach for ragweed pollinosis. Bernstein IL; Tennenbaum J; Georgakis N; Kessler F; Krumholz R Int Arch Allergy Appl Immunol; 1976; 50(2):181-91. PubMed ID: 1107233 [TBL] [Abstract][Full Text] [Related]
63. [Immunotherapy of pollinosis: results of a 2-year study with a new allergen preparation (novo-helisen depot) (author's transl)]. Wüthrich B Schweiz Rundsch Med Prax; 1977 Mar; 66(9):260-6. PubMed ID: 840831 [No Abstract] [Full Text] [Related]
64. Grass pollen hyposensitization versus placebo therapy. II. Immunotherapy-induced changes in serum IgE and IgG levels. Weyer A; Doinel C; Debbia M; L'Heritier C; Rivat L; Le Mao J; Hirth C; David B Allergy; 1981 Jul; 36(5):319-28. PubMed ID: 7032342 [No Abstract] [Full Text] [Related]
65. [Therapy of pollinosis with tyrosine allergoids]. Reinert M; Steurich F MMW Munch Med Wochenschr; 1976 Sep; 118(36):1121-2. PubMed ID: 823406 [No Abstract] [Full Text] [Related]
66. Frequency of booster injections of allergoids. Norman PS; Creticos PS; Marsh DG J Allergy Clin Immunol; 1990 Jan; 85(1 Pt 1):88-94. PubMed ID: 2405042 [TBL] [Abstract][Full Text] [Related]
67. A comparative trial of hyposensitization in 1973 in the treatment of hay fever using Pollinex and Alavac-P. Miller AC Clin Allergy; 1976 Nov; 6(6):551-6. PubMed ID: 827393 [TBL] [Abstract][Full Text] [Related]
68. [Cutaneous foreign body granulomas caused by aluminium-hydroxid after desensitization with h Mischpollen-Depotallergen (author's transl)]. Linse R; Hadlich J; Kirsten D Dermatol Monatsschr; 1979 Sep; 165(9):653-7. PubMed ID: 393554 [TBL] [Abstract][Full Text] [Related]
69. Hyposensitization with emulsified pollen extracts in Britain. Macaulay DB Int Arch Allergy Appl Immunol; 1965; 28(1):12-20. PubMed ID: 5324220 [No Abstract] [Full Text] [Related]
70. Safety of an Accelerated Build-up Phase With Pollen Allergoids: A Retrospective Study. Caruso C; Borgonovo L; Bramé B; Cocconcelli A; Colantuono S; Piantanida M; Scarpa S; Zisa G; Romano A J Investig Allergol Clin Immunol; 2018 Aug; 28(4):283-284. PubMed ID: 30073970 [No Abstract] [Full Text] [Related]
71. Comparison of perennial and preseasonal allergoid immunotherapy in grass pollen allergic patients. Sözener ZC; Mungan D; Aydin Ö; Seçil D; Pinar MN; Demirel YS; Sin BAE Asian Pac J Allergy Immunol; 2023 Mar; 41(1):20-29. PubMed ID: 34246220 [TBL] [Abstract][Full Text] [Related]
73. Sensitization to aluminium by aluminium-precipitated dust and pollen extracts. Castelain PY; Castelain M; Vervloet D; Garbe L; Mallet B Contact Dermatitis; 1988 Jul; 19(1):58-60. PubMed ID: 3180769 [TBL] [Abstract][Full Text] [Related]
74. An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial. Chaker AM; Al-Kadah B; Luther U; Neumann U; Wagenmann M Clin Transl Allergy; 2015; 6():4. PubMed ID: 26839682 [TBL] [Abstract][Full Text] [Related]
75. 13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation. Distler A; Pappelendam D Allergo J Int; 2015; 24():294-302. PubMed ID: 27069842 [TBL] [Abstract][Full Text] [Related]
76. Allergoid-mannan conjugates imprint tolerogenic features in human macrophages. Benito-Villalvilla C; Pérez-Diego M; Subiza JL; Palomares O Allergy; 2022 Jan; 77(1):320-323. PubMed ID: 34601743 [No Abstract] [Full Text] [Related]